Stallergenes Greer

France - Antony

Biotechnology

Website LinkedIn Careers Page

Focus: Allergen Desensitization

Stallergenes Greer is a life sciences company focused on Allergen Desensitization.

UnknownRespiratoryPharmaceutical ProductionPharmaceuticalsAllergy

Open Jobs

Pipeline & Clinical Trials

Oralair

Allergy

N/A

Clinical Trials (1)

NCT02295969Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis

N/A

Clinical, microbiological and inflammatory phenotype

Asthma

N/A

Clinical Trials (1)

NCT03960359Inflammatory and Immune Profiles During a Severe Exacerbation in Preschool Asthmatic Children (<5 Years)

N/A

Evaluation of the Benefits of Sublingual AIT (PRACTIS)

Allergic Rhinitis

N/A

Clinical Trials (1)

NCT06574061Evaluation of the Benefits of Sublingual AIT (PRACTIS)

N/A

Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or

Allergy

N/A

Clinical Trials (1)

NCT04004351Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma

N/A

International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhiniti

Allergic Rhinitis Due to Grass Pollens

N/A

Clinical Trials (1)

NCT02041624International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis

N/A

Placebo

Phase 1

Clinical Trials (1)

NCT00396149Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1

Phase 1

500 IR house dust mites allergen extract tablet

Allergic Rhinitis Due to House Dust Mite

Phase 1

Clinical Trials (1)

NCT01919554Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents

Phase 1

300 IR grass pollen allergen extract tablet

Seasonal Allergic Rhinitis

Phase 1

Clinical Trials (1)

NCT00619827Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract

Phase 1

rBet v 1

Phase 1

Clinical Trials (1)

NCT00889460Safety and Tolerability Study of rBet v1 SLIT Tablets

Phase 1

Sublingual tablet of ragweed pollen allergen extract

Rhinitis, Allergic, Seasonal

Phase 1

Clinical Trials (1)

NCT01224834Safety and Tolerability Study of Ragweed SLIT Tablets

Phase 1

SLIT tablets of house dust mite allergen extracts

Asthma

Phase 1

Clinical Trials (1)

NCT01608243Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts

Phase 1

100 IR house dust mites allergen extract tablet

Allergic Rhinitis Due to House Dust Mite

Phase 2

Clinical Trials (1)

NCT01527188Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment Exposure Chamber Model

Phase 2

Placebo

Phase 2

Clinical Trials (1)

NCT00901914Study of rBet v1 Tablets

Phase 2

Subcutaneous immunotherapy - Recombinant birch pollen

Allergy

Phase 2

Clinical Trials (1)

NCT00410930Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients

Phase 2

SLIT tablets of HDM allergen extracts, 3 different doses

Asthma

Phase 2

Clinical Trials (1)

NCT01930461Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma

Phase 2

300 IR house dust mites allergen extract tablet

Allergic Rhinitis

Phase 2/3

Clinical Trials (1)

NCT00674700Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis

Phase 2/3

100 IR grass pollen allergen extract tablet

Allergy

Phase 2/3

Clinical Trials (1)

NCT00367640Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis

Phase 2/3

300 IR grass pollen allergen extract tablet

Allergy

Phase 3

Clinical Trials (1)

NCT00409409Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis

Phase 3

Staloral

Allergy

Phase 3

Clinical Trials (1)

NCT00660452A Phase III Study to Assess Efficacy and Safety of STALORAL® 300 IR Sublingual Immunotherapy (SLIT) in Asthmatic Patients Allergic to House-dust Mites

Phase 3

Placebo

Hypersensitivity

Phase 3

Clinical Trials (1)

NCT01731249Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis

Phase 3

300 IR

Allergy

Phase 3

Clinical Trials (1)

NCT00418379Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets

Phase 3

Skin prick-test

Allergy

Phase 3

Clinical Trials (1)

NCT01964768Sensitivity and Specificity of 3 Solutions of Allergen Extract for Diagnosis by Skin Prick Testing

Phase 3

STALORAL® Birch 300 IR

Allergic Rhinoconjunctivitis

Phase 3

Clinical Trials (1)

NCT05668390Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma

Phase 3

300 IR

Rhinitis, Allergic, Perennial

Phase 3

Clinical Trials (1)

NCT02443805Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR

Phase 3

300 IR

Allergic Rhinitis Due to Grass Pollens

Phase 3

Clinical Trials (1)

NCT00955825Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis

Phase 3

300 IR house dust mites allergen extract tablet

Allergic Rhinitis Due to Dust Mite

Phase 3

Clinical Trials (1)

NCT01199133Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and Children

Phase 3

300 IR

Primary Disease

Phase 3

Clinical Trials (1)

NCT00803244Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis

Phase 3

Open Jobs (15)

Interview Prep Quick Facts

Portfolio: 27 clinical trials

Top TAs: Respiratory

Open Roles: 15 active jobs

Therapeutic Area Focus

Respiratory

2 pipeline

Marketed

Pipeline

Stallergenes Greer

Pipeline & Clinical Trials

Open Jobs (15)

Rédacteur médical CDD H/F

Chef de Projet Ingénierie CDD H/F

Chef de projet utilités H/F

Pharmacien Assurance Qualité H/F

Manager de Proximité H/F

Responsable Contrôle Qualité H/F

Technicien Conditionnement Comprimés H/F

Chargé de travaux neuf H/F

Technicien de Fabrication H/F

Stage Marketing Pharmaceutique H/F

Ingénieur Energie H/F

Ingénieur production H/F

Approvisionneur H/F

Biostatisticien & Data Manager H/F

Chef de projet clinique RWE H/F